
|
SITE MENU Welcome to DSI For Patients For Industry Industry Resources Place a Trial With Us Why Choose DSI Curriculum Vitae Where to Stay For Doctors About Us Employment Other Sites Site Map |
Handling of Controlled Substances: 21 CFR 312.69 If the investigational drug is subject to the Controlled Substances Act, the investigator shall take adequate precautions, including storage of the investigational drug in a securely locked, substantially constructed cabinet, or other securely locked, substantially constructed enclosure, access to which is limited, to prevent theft or diversion of the substance into illegal channels of distribution. We at DSI have several precautions to adhere to this code, including:
|